| Full Text | |||||||||||||||||||||||||||||||||||||||||
Hypothesis & Experience
| |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
A blog that publishes updates and open access scientific papers about allergy, asthma and immunology. Editor: Juan Carlos Ivancevich, MD. Specialist in Allergy & Immunology
May 21, 2013
Staphylococcal enterotoxin specific IgE and asthma: a systematic review and meta-analysis
Acute eosinophilic pneumonia related to a mesalazine suppository
| Full Text | |||||||||||||||||||||||||||||||||||||
Case Report
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
Purification and Immunobiochemical Characterization of a 31 kDa Cross-Reactive Allergen from Phaseolus vulgaris (Kidney Bean)
- PLoS One
- v.8(5); 2013
- PMC3650053
PLoS One. 2013; 8(5): e63063.
Published online 2013 May 9. doi: 10.1371/journal.pone.0063063
PMCID: PMC3650053
Purification and Immunobiochemical Characterization of a 31 kDa Cross-Reactive Allergen from Phaseolus vulgaris (Kidney Bean)
Ramkrashan Kasera,1,2 Anand Bahadur Singh,1 Shakuntala Lavasa,3 Komarla Nagendra,4 and Naveen Arora1,2,*
William R. Abrams, Editor
Abstract
Background
Legumes are a rich source of proteins but are also potential elicitors of IgE-mediated food allergy. This study aimed to isolate and characterize a major allergen of Phaseolus vulgaris (kidney bean) and determine its allergenicity.
Methodology
Kidney bean allergen was purified using Q Sepharose column (anion exchanger) and eluates with high intensity were pooled to purify protein using Superdex 75 (gel filtration) and C18 column (RP-HPLC). Patients with history of kidney bean allergy were skin prick tested (SPT) with crude kidney bean extract and the purified protein. Specific IgE was estimated in sera by enzyme-linked immunosorbent assay (ELISA). Characterization of purified protein and its cross-reactivity was investigated by immunobiochemical methods. Identification of purified protein was carried out by tandem mass spectrometry.
Principal Findings
Purified protein appeared as a single band at 31 kDa on SDS-PAGE and showed IgE binding to 88% patients’ sera by ELISA and immunoblotting. SPT with purified protein identified 78% hypersensitive patients of kidney bean. Significant release of histamine from sensitized basophils was observed after challenge with purified protein. PAS staining suggested it to be a glycoprotein, but no change in IgE binding was observed after periodate oxidation. The 31 kDa protein remained stable for 60 min on incubation with pepsin. The purified protein had high allergenic potential since it required only 102 ng of self protein for 50% IgE inhibition. Mass spectrometric analysis identified it as Phytohemagglutinin. It also showed hemagglutination with human RBCs. Cross-reactivity was observed with peanut and black gram with IC50 of 185 and 228 ng respectively.
Conclusion/Significance
A 31 kDa major allergen of kidney bean was purified and identified as phytohemagglutinin with cross-reactivity to peanut and black gram.
Formats:
Prospective analysis of human leukocyte functional tests reveals metal sensitivity in patients with hip implant
Prospective analysis of human leukocyte functional tests reveals metal sensitivity in patients with hip implant
Csaba Vermes, József Kuzsner, Tamás Bárdos and Péter Than
For all author emails, please log on.
Journal of Orthopaedic Surgery and Research 2013, 8:12 doi:10.1186/1749-799X-8-12
Published: 16 May 2013Abstract (provisional)
Background
The aim of the study was to examine the reactivity of peripheral human leukocytes to various metal ions prior and following hip replacement in order to investigate implant-induced metal sensitivity.
Methods
Three patient groups were set up: (1) individuals without implants and no history of metal allergy (7 cases), (2) individuals without implants and known history of metal allergy (7 cases), and (3) patients undergoing cementless hip replacement (40 cases). Blood samples were taken in groups 1 and 2 at three different occasions; in group 3, prior and 3, 6, 12, 24, and 36 months after surgery. Peripheral leukocytes were separated and left either untreated or challenged with Ti, NiCl2, CoCl2, CrCl3, and phytohemagglutinin. Cell proliferation, cytokine release, and leukocyte migration inhibition assays were performed. Metal-induced reactivity was considered when all three assays showed significant change. Skin patch tests were also carried out.
Results
Both skin patch tests and leukocyte functional tests were negative in group 1, and both were positive in group 2. In group 3, after 6 months, 12% of the patients showed reactivity to the tested metals except for NiCl2. Following the 36-month period, 18% of group three became sensitive to metals (including all the earlier 12%). In contrast, patch tests were negative at each time point in group 3.
Conclusions
Orthopedic implant material may induce metal reactivity after implantation in a manner where susceptibility is yet to be elucidated. Leukocyte triple assay technique might be a useful tool to test implant material-related sensitivity.
The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production. |
May 20, 2013
Learn the basics of spirometry testing through examples of proper and improper efforts.
Learn the basics of spirometry testing through examples of proper and improper efforts.
May 19, 2013
Formulation strategies for drug delivery of tacrolimus: An overview
- Int J Pharm Investig >
- v.2(4); Oct-Dec 2012 >
- PMC3618632
Int J Pharm Investig. 2012 Oct-Dec; 2(4): 169–175.
PMCID: PMC3618632
Formulation strategies for drug delivery of tacrolimus: An overview
Abstract
Tacrolimus (FK 506) is a potent macrolide lactone immunosuppressive agent used for prophylaxis of organ rejection after transplantation and graft-versus-host disease after bone marrow transplantation in patients. Moreover, tacrolimus is a drug of choice in the treatment of atopic dermatitis for decreasing side effects associated with the use of topical corticosteroids. In spite of its success in ensuring graft survival, therapeutic use of tacrolimus is complicated due to its narrow therapeutic index (between 5 and 15 ng/ml). Tacrolimus has a large inter-/intra-patient variability in pharmacokinetics profile and a poor oral bioavailability because of its poor solubility, P-gp efflux, marked pre-systemic metabolism by CYP3A in the enterocytes and liver first pass effect. Several formulation approaches such as oily solution, solid dispersions, complexation with cyclodextrins, liposomes etc., have been investigated to improve oral delivery of FK 506. In this review, we have discussed various formulation approaches that have been undertaken by various researchers to solve the problems related to the drug delivery of tacrolimus.
Keywords: Bioavailability, drug delivery systems, nanocapsule, self-microemulsifying drug delivery system, tacrolimus
Formats:
- Abstract |
- Article |
- PubReader |
- ePub (beta) |
- Printer Friendly
Articles from International Journal of Pharmaceutical Investigation are provided here courtesy of Medknow Publications
Characterization of food allergies in patients with atopic dermatitis
| ||||||||||||||||||||||||||||||||||||||||
Subscribe to:
Posts (Atom)